Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Selenium-enriched milk proteins (dairy-Se) are a specialized dietary source of selenium produced by incorporating the trace element into milk proteins, typically through the supplementation of dairy cows' diets. Research indicates that dairy-Se is biologically distinct from other selenium supplements, such as selenium yeast. In preclinical models, dairy-Se has been shown to specifically up-regulate the mRNA expression of **Selenoprotein P (SeP)** and **Gastrointestinal glutathione peroxidase-2 (GPx-2)** in the colon, whereas selenium yeast primarily affects GPx-1. This targeted up-regulation of colonic selenoproteins is associated with significant chemopreventive effects against colorectal cancer (CRC), likely by enhancing antioxidant defenses and maintaining mucosal integrity. It is primarily investigated as a nutraceutical intervention for cancer prevention.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on selenium-enriched milk proteins.